ClinicalThought
View More
Current HIV guidelines limit their recommendations for dual ART, but I expect positive data will soon change this.
Omar Sued, MD, PhD
Released: September 20, 2019
The question of which patients are candidates for long-acting ART might be a question of which patients want it.
Andrea Mantsios, PhD
Released: September 27, 2019
Less frequent dosing may be a welcome theme among HIV drugs under investigation.
Babafemi Taiwo, MBBS
Released: October 10, 2019
Why I believe as many as 70% of my patients will be interested in long-acting injectable ART.
Anthony M. Mills, MD
Released: December 11, 2019
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.